News ImmunityBio warned by FDA over 'misleading' Anktiva content The FDA has sent a warning letter to ImmunityBio over "false and misleading" comments made by executive chair, billionaire Patrick Soon-Shiong.
Oncology Servier’s ASCO 2025 data: Advancing IDH-mutated cancer treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
News Top podcaster spread health misinformation, claims BBC probe Prominent podcaster Steven Bartlett has been accused of allowing health misinformation to be shared on his Diary of a CEO stream.
Digital Unlocking biotech insights: Top 10 podcasts you need to list... In the fast-paced world of biotechnology, staying informed and connected is key to success.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.